MedPath

The effectiveness of Vitagnos, Gabapentin and Paroxetine on early menopause complications

Phase 3
Conditions
early complications of menopause.
Menopausal and other perimenopausal disorders
Registration Number
IRCT20181208041882N16
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

Age 45 to 60 years
Amenorrhea for at least 12 months
At least 3 hot flushes in 24 hours

Exclusion Criteria

Women with abnormal menopause
Patients with chronic diseases (thyroid disease, psychosomatic disease, pheochromocytoma, carcinoid, leukemia, cancer and other known systemic diseases such as hypertension, diabetes, heart diseases)
Consumption of hormones and supplements (containing estrogen-like compounds such as soy)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Menopause symptoms. Timepoint: Week 0, 4 and 8. Method of measurement: based on Kupperman Index.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath